CLASS II ONGOING Device recall · Reported 14 Sep 2022 · FDA Enforcement Report

Early Bird Bleed Monitoring System Introducer Sheath Set recalled

Saranas is recalling Early Bird Bleed Monitoring System Introducer Sheath Set, distributed nationwide in the US. The recall was initiated on 10 Aug 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/REF/Lot: 00866532000402/FG001-01/510090S, 511110A, 510120F, 102422, 102445, 102531, 102671, 102685, 102731; 00866532000419/FG001-02/515070A, 528090C, 510120G, 511110B, 102567, 102610, 102611
Quantity recalled953

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1684-2022
FDA event ID
90725
Recalling firm
Saranas, Houston, TX
Classification
Class II
Status
Ongoing
Recall initiated
10 Aug 2022
FDA classified
7 Sep 2022
Reported
14 Sep 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Aug 2022Recall initiated by company
7 Sep 2022Classified by FDA+28 days
14 Sep 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Bleed monitoring system device design error, causing the device to not power on and complete the series of self-tests so instructions for use being updated to include device check before use ensure that the device is functioning appropriately.

Product as listed by the FDA

Early Bird Bleed Monitoring System Introducer Sheath Set, REF: FG001-01 (6F), FG001-02 (8F)

Where it was distributed

US Nationwide distribution including in the states of PA, MI, FL, WV, TX, NJ, GA, LA, NY, MA, CT, AZ, OH, TN, VA.

Nationwide ArizonaConnecticutFloridaGeorgiaLouisianaMassachusettsMichiganNew JerseyNew YorkOhioPennsylvaniaTennesseeTexasVirginiaWest Virginia

Questions about this recall

Why was it recalled?

Bleed monitoring system device design error, causing the device to not power on and complete the series of self-tests so instructions for use being updated to include device check before use ensure that the device is functioning appropriately.

Which lots are affected?

UDI/REF/Lot: 00866532000402/FG001-01/510090S, 511110A, 510120F, 102422, 102445, 102531, 102671, 102685, 102731; 00866532000419/FG001-02/515070A, 528090C, 510120G, 511110B, 102567, 102610, 102611

Where was it sold?

US Nationwide distribution including in the states of PA, MI, FL, WV, TX, NJ, GA, LA, NY, MA, CT, AZ, OH, TN, VA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Heart & Vascular Devices recalls

All 6,199